Literature DB >> 1331523

Herpes simplex virus type 1 mutant strain in1814 establishes a unique, slowly progressing infection in SCID mice.

T Valyi-Nagy1, S L Deshmane, B Raengsakulrach, M Nicosia, R M Gesser, M Wysocka, A Dillner, N W Fraser.   

Abstract

Ocular infection of immunocompetent (BALB/c) mice with wild-type herpes simplex virus type 1 (HSV-1) 17+ may lead to acute fatal encephalitis; however, in surviving animals, a latent (nonproductive) infection of the nervous system is established. In contrast, 17+ infection invariably kills mice with severe combined immunodeficiency (SCID mice) within 2 weeks. Ocular infection of immunocompetent mice with a mutant HSV-1 strain, in1814, which does not produce a functional alpha-transinducing protein, results in no detectable viral replication in the nervous system during the time corresponding to the acute phase of infection, no mortality, and the establishment of latency. In SCID mice, however, the in1814 virus establishes a unique, slowly progressing infection. In studying the courses of in1814 infection in SCID and BALB/c mice, we found that although intact B- and/or T-lymphocytic functions were required for the control of viral replication in the nervous system, some of the infected neurons of SCID mice seemed to be able to restrict in1814 replication and harbor the virus in a latent state.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331523      PMCID: PMC240438     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Latent herpes simplex virus type 1 transcripts in peripheral and central nervous system tissues of mice map to similar regions of the viral genome.

Authors:  A M Deatly; J G Spivack; E Lavi; D R O'Boyle; N W Fraser
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

Review 2.  An inquiry into the mechanisms of herpes simplex virus latency.

Authors:  B Roizman; A E Sears
Journal:  Annu Rev Microbiol       Date:  1987       Impact factor: 15.500

3.  Latent herpes simplex virus type 1 DNA contains two copies of the virion DNA joint region.

Authors:  D L Rock; N W Fraser
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

4.  Proteins specified by herpes simplex virus. V. Purification and structural proteins of the herpesvirion.

Authors:  P G Spear; B Roizman
Journal:  J Virol       Date:  1972-01       Impact factor: 5.103

5.  Nerve growth factor deprivation results in the reactivation of latent herpes simplex virus in vitro.

Authors:  C L Wilcox; E M Johnson
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

6.  Detection of herpes simplex virus-specific DNA sequences in latently infected mice and in humans.

Authors:  S Efstathiou; A C Minson; H J Field; J R Anderson; P Wildy
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

7.  Passive immunization protects the mouse eye from damage after herpes simplex virus infection by limiting spread of virus in the nervous system.

Authors:  C Shimeld; T J Hill; W A Blyth; D L Easty
Journal:  J Gen Virol       Date:  1990-03       Impact factor: 3.891

8.  Herpes simplex virus type 1 infection in mice with severe combined immunodeficiency (SCID).

Authors:  H Minagawa; S Sakuma; S Mohri; R Mori; T Watanabe
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

9.  Herpes simplex virus type 1 latency-associated transcripts are evidently not essential for latent infection.

Authors:  I Steiner; J G Spivack; R P Lirette; S M Brown; A R MacLean; J H Subak-Sharpe; N W Fraser
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

10.  Latent herpes simplex virus in the central nervous system of rabbits and mice.

Authors:  F B Knotts; M L Cook; J G Stevens
Journal:  J Exp Med       Date:  1973-09-01       Impact factor: 14.307

View more
  19 in total

1.  Therapeutic implications of new insights into the critical role of VP16 in initiating the earliest stages of HSV reactivation from latency.

Authors:  Richard L Thompson; Nancy M Sawtell
Journal:  Future Med Chem       Date:  2010-07       Impact factor: 3.808

Review 2.  Experimental investigation of herpes simplex virus latency.

Authors:  E K Wagner; D C Bloom
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

3.  BAC-VAC, a novel generation of (DNA) vaccines: A bacterial artificial chromosome (BAC) containing a replication-competent, packaging-defective virus genome induces protective immunity against herpes simplex virus 1.

Authors:  M Suter; A M Lew; P Grob; G J Adema; M Ackermann; K Shortman; C Fraefel
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

4.  Optimized viral dose and transient immunosuppression enable herpes simplex virus ICP0-null mutants To establish wild-type levels of latency in vivo.

Authors:  W P Halford; P A Schaffer
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

5.  Herpes simplex virus type 1 encephalitis is associated with elevated levels of F2-isoprostanes and F4-neuroprostanes.

Authors:  Dejan Milatovic; Yueli Zhang; Sandra J Olson; Kathleen S Montine; L Jackson Roberts; Jason D Morrow; Thomas J Montine; Terence S Dermody; Tibor Valyi-Nagy
Journal:  J Neurovirol       Date:  2002-08       Impact factor: 2.643

6.  Extreme susceptibility of African naked mole rats (Heterocephalus glaber) to experimental infection with herpes simplex virus type 1.

Authors:  James Artwohl; Susan Ball-Kell; Tibor Valyi-Nagy; Steven P Wilson; Ying Lu; Thomas J Park
Journal:  Comp Med       Date:  2009-02       Impact factor: 0.982

7.  Varicella-zoster virus open reading frame 10 is a virulence determinant in skin cells but not in T cells in vivo.

Authors:  Xibing Che; Leigh Zerboni; Marvin H Sommer; Ann M Arvin
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

8.  Towards an understanding of the herpes simplex virus type 1 latency-reactivation cycle.

Authors:  Guey-Chuen Perng; Clinton Jones
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-02-15

9.  Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection.

Authors:  T Liu; Q Tang; R L Hendricks
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

10.  Persistence of herpes simplex virus type 1 DNA in chronic conjunctival and eyelid lesions of mice.

Authors:  D J Maggs; E Chang; M P Nasisse; W J Mitchell
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.